Nevra Alkanli

18PUBLICATIONS
25CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 16, 2026
Genetic Risk Factors of Neurodegeneration: The Role of MMP1 rs1799750 (-1607 1G/2G), MMP2 [rs243865 (-1306 C > T), rs2285053 (-735 C > T), and MMP3 rs3025058 (-1171 5A/6A) Genetic Variants in Multiple Sclerosis Pathogenesis.

|Aug 27, 2026
Impact of MMP1, MMP2, and MMP3 Gene Variations on Susceptibility to Peyronie's Disease and Clinical Progression.

|Jul 15, 2026
Genetic Susceptibility to Diabetic Retinopathy in the Thrace Region: Role of IL-18 (-607 C/A, -137 G/C) and IL-8 (-251 A/T) Variations.

|Jun 26, 2026
Inflammatory Cytokine Genetics and Coronary Artery Disease: Pathogenetic and Protective Analysis of IL-18 (-607 C/A, -137 G/C) and IL-8 (+781 C/T) Gene Variations.

|May 13, 2026
Differential Roles of IL-18 and IL-8 Gene Variations in Multiple Sclerosis: Associations with Susceptibility and MRI Disease Activity.

|Jan 30, 2026
Investigation of the Correlation Between Selected miRNAs, Proinflammatory Cytokines, and Serum Trace Elements in Bladder Cancer Development and Progression.

Arzu Ay, Nevra Alkanli, Engin Atli

Pageof 3

Frequent Collaborators

17 joint publications

Arzu Ay

7 joint publications

Gokhan Cevik

4 joint publications

Necdet Sut

3 joint publications

Tammam Sipahi